Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant investments in India, is organising 'MTaI MedTekon 2018' to bring together healthcare experts for devising a mechanism to ensure Pradhan Mantri Jan Arogya Abhiyan addresses all stakeholders adequately.
Pradhan Mantri Jan Arogya Abhiyan (PRAJAA), which was called Ayushman Bharat - National Health Protection Scheme (AB-NHPS) earlier, will provide health insurance worth Rs. 5 lakh per family. It will cover 50 crore people, or nearly 40% of India's population. The scheme is scheduled for a formal launch on September 25.
MTaI MedTekon 2018 will be organised on 20th September 2018 with representation from the government, NITI Aayog, hospitals, pharmaceuticals industry, medical device manufacturers, doctors, et. al. to deliberate on the role medical technology sector can play in conjunction with other stakeholders for successful implementation of the scheme. MTaI will share the key findings and recommendations of the summit with the government for consideration.
"India has one of the lowest health insurance penetration in the world. As a result, a significant portion of the population is out of the purview of formal healthcare services. In this scenario, PRAJAA is a ground-breaking scheme that will make healthcare affordable without adding any financial burden to the user," MTaI Chairman and Director General Mr. Pavan Choudary said.
Badhri Iyengar, Chairman of MTaI MedTekon 2018 said, "From the industry's perspective, the size of healthcare industry is expected to reach $372 billion by 2022-23 from $160 billion in 2017. How we can club this growth with healthcare services through smooth implementation of NHPS is a subject that requires further discussion."
"We seek to address this subject in detail at MTaI MedTekon 2018 with participation from the government, NITI Aayog, and all segments of healthcare value chain. Foreign healthcare delegates will share key learnings of public health schemes in other countries," added Diwaker Rana, Co-chairman of MTaI MedTekon 2018.
Disclaimer: No Business Standard Journalist was involved in creation of this content
